Brad Mathis's Location
San Antonio, Texas, United States, United States
Brad Mathis's Contact Details
Brad Mathis work email
- Valid
- Valid
- Valid
- Valid
- Valid
Brad Mathis personal email
n/a
Brad Mathis phone numbers
About Brad Mathis
As a diversified leader with a strong track record of success my experience has been affiliated with 5 different pre-commercial start ups with direct responsibility and oversight for advancing assets to market. I have personally been involved in the development and oversight of 5 of the 6 products I have been associated with in the last 15+ years. As a highly accomplished and forward-thinking Biotech Executive with extensive global and domestic experience in pharmaceutical sales, marketing, operations, market access, sales training, product commercialization, regional sales, product launch and business development. Therapeutic areas of focus in rare diseases, including hematology, oncology, nephrology, pediatric hematology and neurology. Possesses a proven track record of generating revenue and boosting corporate performance by developing key top performance through transparent and accountable leadership. Motivates others to drive towards and achieve a common goal with close coordination with contributing functional areas.
Brad Mathis's Current Company Details
Brad Mathis Work Experience Details
-
Management ConsultantQral GroupBel Air, Md, Us
-
Chief Executive OfficerRenovo Concepts, Inc. Jul 2024 - PresentMechanical Tissue Resuscitation™ (MTR™) is a revolutionary, transformative technology to actively remove excess fluids in damaged tissues of the brain, heart and spine to help mitigate the effects of secondary injury. With the use of a controlled application of sub-atmospheric pressure in the treatment of injuries, MTR™ offers a new therapeutic modality in a field that has seen little innovation in care -
Founder And Chief Operating OfficerEntropy Bio Sep 2021 - Jul 2024At Entropy Bio, we are dedicated to discovering and developing the most impactful and advanced therapeutics for rare disease and cancer by seeking the root cause of disease, exploiting the recent explosion of biological knowledge, and fueling experienced teams with predictive platforms and infrastructure to innovate. -
Chief Operating OfficerHealthtech Solutions, Inc. Jul 2021 - Sep 2021 -
Head Of The Us Neurology FranchiseArgenx Nov 2019 - Feb 2021Boston, Ma, Us -
Vice President & Gm, Us Commercial OperationsOrchard Therapeutics Jun 2018 - Nov 2019London, United Kingdom, GbOrchard Therapeutics is a clinical stage biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative gene therapies. Our vision is to become the leader in gene therapy for primary immune deficiencies and inherited metabolic disorders. -
Vp & Gm, Head Of Us CommercialSucampo Pharmaceuticals, Inc. (Acquired By Mallinckrodt Pharma) Aug 2017 - Apr 2018Developed successful commercialization and launch plans for VTS-270 for NPC, a lysosomal storage disorder. Led on-going build-out and management of US customer-facing functions. Developed and executed strategic sales plan as well as hired and established US commercial field positions within sales, marketing, market access, diagnostics, and clinical thought leaders. Prepared the market for the launch of VTS-270 for NPC prior to corporate acquisition by Mallinckrodt Pharmaceuticals in April 2018.Through strategic data analysis I led the identification of 287 patients, exceeding acquisition target estimate at peak sales prior to launch. Oversaw strategic diagnostic project to add NPC to newborn screening panel (RUSP) for all babies born in US. Delivered fully executable business plans for launch of VTS 270. Presented launch plan to the Board of Directors highlighting Strategic Pillars and Critical Initiatives regarding patient identification, ensuring access to high quality testing and establishing US Salesforce size and structure.Leveraged key relationships with the NIH to support better understanding of the patient journey and inform on opportunities to educate resulting in improved diagnostics for early diagnosis and intervention.
-
Executive Director Of Us SalesAlexion Pharmaceuticals, Inc. Sep 2015 - Aug 2017Boston, Massachusetts, UsManaged team of six regional directors and 42 regional managers to achieve and exceed sales targets for complement franchise calling on hematologists, nephrologists, hospitalists, hematopathologists, and intensivists for indications of PNH and aHUS. Collaborated closely with US marketing teams to impact marketing plans. Drove US marketing plan through key strategy and tactics by identifying patients, generating demand, creating access, and supporting appropriate utilization. Managed annual budget for area and regional US sales team. Executed and oversaw regional quarterly business reviews as well as served in quarterly executive business reviews. Assembled team and staffed regional sales directors and regional account managers. Led team to deliver $1,600,000,000 in annual revenue and double-digit growth. Achieved area US sales performance targets through development and execution of strategic/tactical regional sales plans. Delivered highest record quarter ever in newly identified and net new patients since launch Q2, 2016.Actively reviewed performance metrics with sales directors to ensure sales team achieved maximum sales results from assigned territories.Established favorable and on-going partnership with patient access services support team and STAR team partners to ensure success of Soliris and patients’ access to therapy. Ensured appropriate leadership and development of team by defining clear objectives, allocating resources, monitoring activities, distributing fair rewards and sales incentive plans, as well as providing developmental opportunities. -
Sr. Director, Market AccessAlexion Pharmaceuticals, Inc. Oct 2013 - Sep 2015Boston, Massachusetts, UsDeveloped, implemented and influenced collaborative to ensure access to Soliris (Eculizumab) for ultra-orphan population of patients with PNH, aHUS and Asfotase Alfa for HPP. Created and led top-performing national team executing ultra-orphan business strategy with regards to payers, PBMs and SPP for all approved indications. Aligned business strategy and plans to provide support for case management and patients in overturning denials and restrictive funding criteria, including development and implementation of coverage policies for Soliris (Eculizumab) for PNH or aHUS. Created HEOR story with medical affairs using premier database to prove Soliris as cost-effective option in hospital. Demonstrated $100,000 in savings per patient by using Soliris to quickly address disease. Collaborated with pharmacy to start therapy, saving patients’ lives. Led development and implementation of strategic planning to ensure payer program criteria are favorable for access to Alexion products with unified message supporting appropriate use backed by clinical resources.Actively engaged medical affairs to develop clinical strategies to support access to Soliris and Asfotase Alfa for appropriate patients.Collaborated with government affairs to ensure support/coverage for public payers, including Medicare, Medicaid, and 340B.Acted as team lead for access and reimbursement in launch team planning, including partnership development with customer operations to enable access to Asfotase Alfa, ensuring flawless execution of HPP launch plan through specialty pharmacy distribution channel.
-
Sr. Director; Us Marketing, NephrologyAlexion Pharmaceuticals, Inc. Nov 2011 - Oct 2013Boston, Massachusetts, UsManaged team of directors, associate directors and senior managers to execute strategic objectives for market development, indication growth and patient retention strategy. Focused brand strategy on digital, non-personal, patient(DTC) and HCP Nephrology Specialty. Managed $12,500,000 budget. Oversaw situational assessment development, strategic plan development, tactical plan creation and quarterly presentations to CEO and CFO regarding comprehensive business updates.Led US nephrology marketing launch for Soliris second indication for aHUS to most successful ultra-orphan launch in US history.Developed and led genetic testing project for patients with AHUS, resulting in collaborative partnership with key academic institutions Washington University in St. LouisIdentified solution for share of voice by placing primary focus on hematologists as they prescribed majority of product. Rolled all of marketing together as best structure for business. Worked with FDA and legal team to develop/promote supporting materials to ensure corporate compliance despite restrictive conditions under accelerated approval.Conducted weekly assessment of US KPI metrics for performance and analysis, delivering on all metrics.
-
Director Of Global Training And DevelopmentAlexion Pharmaceuticals, Inc. Sep 2009 - Nov 2011Boston, Massachusetts, UsOversaw training department. Managed global infrastructure for training and development across 50 countries, supporting clinical training for Soliris in PNH and aHUS. Served as global trainer. Built and executed comprehensive module system to standardized training curriculum. Led through continuum from development to implementation of sales training modules. Adapted training content and materials for Japan, Brazil, Argentina, France, Germany, Spain, EMEA and the Nordics. Worked with medical to develop scientific platform. Presented data and conducted training classes. Hired and developed US/international Trainers which included four in US and one in Switzerland.Initiated and executed LMS project identification and implementation to support assessment/accountability of clinical training worldwide. Developed global footprint for world-class training department.Won chairman's award of excellence for exceptional performance.
-
Regional Sales DirectorAlexion Pharmaceuticals, Inc. Jan 2007 - Sep 2009Boston, Massachusetts, UsLed team of eight regional account managers covering central US from Texas to Michigan for launch of first indication in hematology. Managed team to achieve corporate objectives to identify new patients, create access, and support appropriate utilization. Oversaw strategic planning and execution of sales plans. Established appropriate relationships with KOL audience. Supported resource allocation as well as continued growth and development through clinical acumen, business acumen and appropriate coaching. Served as mentor for new regional sales manager hires.Acted as regional sales director lead for field diagnostics team initiatives.Led team through three US expansions.Consistently met or exceeded corporate objectives.
-
Sr Sales ManagerBristol Myers Squibb Mar 2005 - Jan 2007Lawrence Township, Nj, UsResponsibilities included hiring the initial sales team for the launch of Orencia, a biologic for RA. Position reported to the Vice President of Sales, Southwest Region. -
Regional Sales ManagerBiogen Idec 2002 - 2005Cambridge, Ma, UsRegional Sales Manager for a team of Sales Representatives selling a biologic for Psoriasis. The product was sold off in 2005.
Brad Mathis Skills
Biotechnology
Hematology
Pharmaceutical Industry
Product Launch
Pharmaceutical Sales
Market Access
Marketing Strategy
Oncology
Nephrology
Hospital Sales
Management
Rheumatology
Sales Management
Sales
Market Research
Selling
Brad Mathis Education Details
-
Texas Tech UniversityEconomics -
Texas Tech UniversityEconomics
Frequently Asked Questions about Brad Mathis
What company does Brad Mathis work for?
Brad Mathis works for Qral Group
What is Brad Mathis's role at the current company?
Brad Mathis's current role is Management Consultant.
What is Brad Mathis's email address?
Brad Mathis's email address is ma****@****lxn.com
What is Brad Mathis's direct phone number?
Brad Mathis's direct phone number is +120327*****
What schools did Brad Mathis attend?
Brad Mathis attended Texas Tech University, Texas Tech University.
What skills is Brad Mathis known for?
Brad Mathis has skills like Biotechnology, Hematology, Pharmaceutical Industry, Product Launch, Pharmaceutical Sales, Market Access, Marketing Strategy, Oncology, Nephrology, Hospital Sales, Management, Rheumatology.
Who are Brad Mathis's colleagues?
Brad Mathis's colleagues are Emily Berg, Bhavik Gandhi, Yatendra Upadhyay, Claire Park, Sumeet Chahal, Jillian Rochelle, Jade B..
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial